1. Catalogs
  2. RedDress
  3. ActiGraft Case Studies

ActiGraft Case Studies

ActiGraft Case Studies

ActiGraft Case Studies

Product catalog summary
Patient Overview: The document details multiple case studies of patients with chronic wounds, primarily focusing on the use of ActiGraft treatment. The patients are elderly males with various comorbidities such as congestive heart failure, atrial fibrillation, diabetes, and neuropathy.
Case Study 1: A 98-year-old male with a stage 4 right heel ulcer and chronic osteomyelitis. Previous treatments included Santyl, mesalt, VAC, and others. ActiGraft was applied weekly, promoting wound healing by recreating the natural healing environment.
Case Study 2: A 74-year-old male with a similar medical history and wound condition as Case Study 1. The patient had a 19-week-old ulcer and received ActiGraft treatment, showing progression over several weeks.
Case Study 3: A 67-year-old paraplegic male with a diabetic ulcer on the right medial foot. The ulcer was 89 weeks old, and past treatments included wet-to-dry dressings and antibacterial agents. ActiGraft treatment was applied, showing improvement over time.
Case Study 4: A 77-year-old male with a diabetic ulcer and a history of smoking. The ulcer was 30 weeks old, and past treatments included skin grafts and surgical debridement. ActiGraft was used, with documented wound area reduction over time.
ActiGraft Treatment: ActiGraft is a patented coagulation formula that uses the patient's blood to create a topical dressing, promoting wound healing for up to 7 days with weekly applications. It is effective on various types of wounds, including vascular and diabetic ulcers.
Offloading Techniques: Patients used heel offloading boots and wheelchairs to reduce pressure on the affected areas, aiding in the healing process.
Conclusion: The document highlights the effectiveness of ActiGraft in treating chronic wounds in patients with complex medical histories, emphasizing the importance of offloading and consistent treatment application.
See more

Catalog excerpts

ActiGraft Case Studies-1

RECREATING THE NATURAL WOUND HEALING ENVIRONMENT ActiGraft is a patented coagulation formula that rapidly transfers the patient’s own blood into a powerful whole blood topical dressing reactivating the natural healing cascade. ActiGraft continuously promotes wound healing for 7 days with 1 application weekly. ActiGraft is effective on: • Vascular Wounds • Skin Tears • Diabetic Foot Ulcers • Post-surgical Wounds • Pressure Injury Wounds PATIENT: 98 year-old, white male with congestive heart failure, atrial fibrillation (long-term coumadin), vitamin D deficiency, malnourishment and anemia, venous stasis disease. LABS & DIAGNOSIS: Lab results collected in December 2018 detailing H/H 8.9/31.5, albumin 2.4. Patient diagnosed with stage 4 right heel, chronic osteomyelitis, right foot and ankle. WOUND HISTORY: • Admitted after hospitalization for L femure fracture • 8 month-old ulcer • Boggy heels assessed upon admission • DTI injury developed into a Stage 4 with exposed bone • MRI showed osteomyelitis • ID consult with no further Anbx recommended PAST TREATMENTS: Santyl and mesalt, VAC, optifoam, puracol, iodoform and dry dressing with chrushed Flagyl for odor, VAC. OFFLOADING: Heel offloading boots worn 24/7; the patient was in his wheel chair for most of the day. ACTIGRAFT TREATMENT PROGRESSION:

 Open the catalog to page 1
ActiGraft Case Studies-2

74 year-old, white male with congestive heart failure, atrial fibrillation (long-term coumadin), vitamin D deficiency, malnourishment and anemia, venous stasis disease. LABS & DIAGNOSIS: Lab results collected in December 2018 detailing H/H 8.9/31.5, albumin 2.4. Patient diagnosed with stage 4 right heel, chronic osteomyelitis, right foot and ankle. WOUND HISTORY: • Admitted to LTC 4.14.18 after hospitalization for L femur fracture • 19 week old ulcer • Boggy heels assessed upon admission • DTI injury developed into a Stage 4 with exposed bone • MRI showed osteomyelitis • ID consult with no further...

 Open the catalog to page 2
ActiGraft Case Studies-3

CASE STUDY 3 PATIENT: 67 year-old, paraplegic male. PAST MEDICAL HISTORY: DM2, Neuropathy, HTN, HPL, Anemic, OA. LABS Labs 5/30/14 - HbA1C 8.6, RBC 4.21, HGB/HCT 37, Platelet 92, PTT 22.9. WOUND HISTORY: • Diabetic Ulcer 2A right medial foot • 89 week-old ulcer • 2.60 cm2 X 0.3 cm, draining small amounts of serous/ sanquinous • ABI results for the affected leg = 0.90 PAST TREATMENTS: Wet-to-dry, foam, silver alginate, antibacterial agents, HBO. OFFLOADING: Wheel chair bound.

 Open the catalog to page 3
ActiGraft Case Studies-4

77 year-old, white male. PAST MEDICAL HISTORY: DM2, Neuropathy, PVD, Gout, Afib, HTN, HPL, OA, History of smoking/15 pack years. V=Weekly Application WOUND HISTORY: • Diabetic Ulcer 2A right medial foot, onset • 30 week-old ulcer • 3.96 cm2 X 0.5 cm, moderate amounts of serous/ PAST TREATMENTS: Wet-to-dry, foam, silver alginate, Anbx agents, HBO, skin graft, skin substitute, regular surgical debridement. sanquinous drainage • ABI results for the affected leg = 1.11 ACTIGRAFT TREATMENT PROGRESSION: Day 0 To learn more about ActiGraft, please visit www.reddressmedical.com. RedDress USA 822 A1A...

 Open the catalog to page 4

All RedDress catalogs and technical brochures

Related Searches
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.